Stockscreener 앱 받기
0.3561
4.33%
-0.0161
시간 외 거래:
.34
-0.0161
-4.52%
전일 마감가:
$0.3722
열려 있는:
$0.34
하루 거래량:
359.62K
Relative Volume:
0.05
시가총액:
$5.80M
수익:
$466.90K
순이익/손실:
$-19.82M
주가수익비율:
-0.1246
EPS:
-2.8575
순현금흐름:
$-5.90M
1주 성능:
-9.44%
1개월 성능:
+0.00%
6개월 성능:
-84.17%
1년 성능:
-91.66%
1일 변동 폭
$0.333
$0.3561
1주일 범위
$0.332
$0.404
52주 변동 폭
$0.3311
$5.20
Mangoceuticals Inc Stock (MGRX) Company Profile
명칭
Mangoceuticals Inc
전화
(833) 626-4679
주소
15110 DALLAS PKWY, SUITE 600, DALLAS
Compare MGRX vs VEEV, TEM, BTSG, HQY, MMED
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MGRX
Mangoceuticals Inc
|
0.3561 | 6.06M | 466.90K | -19.82M | -5.90M | -2.8575 |
|
VEEV
Veeva Systems Inc
|
185.59 | 30.25B | 3.20B | 908.91M | 1.42B | 5.4155 |
|
TEM
Tempus Ai Inc
|
48.74 | 8.70B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
43.99 | 8.27B | 12.91B | 104.80M | 394.69M | 0.8769 |
|
HQY
Healthequity Inc
|
81.13 | 6.80B | 1.29B | 191.83M | 362.67M | 2.182 |
|
MMED
Minimed Group Inc
|
17.11 | 4.71B | 0 | 0 | 0 | 0.00 |
Mangoceuticals Inc 주식(MGRX)의 최신 뉴스
Mangoceuticals files $73 million lawsuit against tech vendor By Investing.com - Investing.com South Africa
Mangoceuticals Files $73 Million Lawsuit Against Clarity Ventures Over Alleged Contract Breach - geneonline.com
Mangoceuticals Sues Former Tech Partner Over Platform Dispute - TipRanks
Mangoceuticals announces lawsuit seeking damages exceeding $73 million against Clarity Ventures - marketscreener.com
Mangoceuticals files $73 million lawsuit against tech vendor - Investing.com
Mangoceuticals Announces Lawsuit Seeking Damages Exceeding $73 Million Against Clarity Ventures - TradingView
Mangoceuticals Announces Lawsuit Seeking Damages Exceeding $73 Million Against Former Technology Consulting and Software Development Firm, Clarity Ventures, Inc. - The Manila Times
Jacob Cohen option repricing at Mango - TradingView
[8-K] MANGOCEUTICALS, INC. Reports Material Event | MGRX SEC FilingForm 8-K - Stock Titan
Mangoceuticals Announces Lawsuit Seeking Damages Exceeding - GlobeNewswire
Mangoceuticals stock surges on early success of subscription TRT model - MSN
Merger Talk: Is Mangoceuticals Inc stock a top performer YTD2026 Retail Activity & Growth Oriented Trading Recommendations - baoquankhu1.vn
Aug Breakouts: Can Mangoceuticals Inc ride the EV wave2026 Earnings Surprises & Weekly High Return Stock Opportunities - baoquankhu1.vn
Mangoceuticals stock skyrockets 50% Friday: What's driving the rally? - MSN
MGRX PE Ratio & Valuation, Is MGRX Overvalued - Intellectia AI
Analyst Downgrade: Can Mangoceuticals Inc expand into new marketsEarnings Recap Report & Reliable Volume Spike Alerts - baoquankhu1.vn
Mangoceuticals, Inc. Files International Patent Application for Innovative Antiviral Feed Additive Technology MGX-0024 - Quiver Quantitative
Mangoceuticals, Inc. announces percent patent filing for MGX-0024 antiviral technology to include inhibiting respiratory or orally acquired virus infection in animals or birds - marketscreener.com
Mangoceuticals, Inc. Announces Pct Patent Filing for Mgx-0024 Antiviral Technology - marketscreener.com
MGRX SEC FilingsMangoceuticals, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Zero respiratory deaths in 29,000 birds sparks global patent bid - Stock Titan
MGRX Earnings History & Surprises | EPS & Revenue Results | MANGOCEUTICALS INC (NASDAQ:MGRX) - ChartMill
Aug Closing: Is Mangoceuticals Inc a momentum stockJuly 2025 Gainers & Community Verified Trade Signals - baoquankhu1.vn
MGRX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Institution Moves: Can Mangoceuticals Inc deliver consistent dividendsWeekly Stock Analysis & Community Consensus Trade Signals - baoquankhu1.vn
MGRX Should I Buy - Intellectia AI
Can Mangoceuticals Inc ride the EV waveJuly 2025 Earnings & Free Community Supported Trade Ideas - baoquankhu1.vn
Mangoceuticals reports data on antiviral compound for poultry By Investing.com - Investing.com India
Mangoceuticals' MGX-0024 achieves zero respiratory-related mortality, shows H5N1 prophylactic benefit - marketscreener.com
Mangoceuticals’ MGX-0024 Achieves Zero Respiratory-Related Mortality, Shows H5n1 Prophylactic Benefit - TradingView
Mangoceuticals Highlights Promising MGX-0024 Poultry Antiviral Data - TipRanks
Mangoceuticals reports data on antiviral compound for poultry - Investing.com
Mangoceuticals’ Patented MGX-0024 Achieves Zero Respiratory-Related Mortality in 29,000-Bird Field Trials and Demonstrates Prophylactic Benefit Against H5N1 in Controlled Government Study - The Manila Times
Mangoceuticals, Inc. Reports Promising Results for Antiviral Compound MGX-0024 in Poultry Respiratory Disease Management - Quiver Quantitative
Mangoceuticals (MGRX) reports zero respiratory deaths in 29,000 MGX-0024-treated birds - Stock Titan
Mangoceuticals’ Patented MGX-0024 Achieves Zero - GlobeNewswire
Penny Stocks To Follow NowFebruary 21st - MarketBeat
Mangoceuticals stock slips before the bell after a 49% surge — what traders watch next for MGRX - TechStock²
Penny Stocks To Watch TodayFebruary 20th - MarketBeat
Will Mangoceuticals Inc. stock pay special dividendsJuly 2025 Macro Moves & AI Enhanced Trading Alerts - mfd.ru
These stocks are the most active in today's session - ChartMill
MGRX (Mangoceuticals, Inc., NASDAQ) up 50.75% intraday 20 Feb 2026: TRT sales drive heavy volume - Meyka
Mangoceuticals (MGRX) Stock Surges 70% on TRT Program Growth - parameter.io
How sensitive is Mangoceuticals Inc to inflationPortfolio Value Report & Proven Capital Preservation Methods - baoquankhu1.vn
Mangoceuticals Stock Surges On Early Success Of Subscription TRT Model - Benzinga
Mangoceuticals stock surges on TRT program growth - Investing.com South Africa
Mangoceuticals stock surges on TRT program growth By Investing.com - Investing.com Canada
Here’s Why Mangoceuticals Stock (MGRX) Rocketed Today - TipRanks
12 Consumer Staples Stocks Moving In Friday's Pre-Market Session - Benzinga
Mangoceuticals Accelerates Growth With New Testosterone Therapy Program - TipRanks
MangoRx Experiences Initial Success with Newly Launched - GlobeNewswire
Mangoceuticals Inc (MGRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Mangoceuticals Inc 주식 (MGRX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| JOHNSTON EUGENE M | CFO |
Dec 09 '25 |
Sale |
1.20 |
5,000 |
5,975 |
123,333 |
| JOHNSTON EUGENE M | CFO |
Dec 05 '25 |
Sale |
1.13 |
10,000 |
11,280 |
128,333 |
5.94%
자본화:
|
볼륨(24시간):